Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has successfully completed its acquisition, doubling its stake in Tianjin Pharmaceutical Group Finance Co., Ltd. from 15% to 30%, thereby making it an associated company. The completion followed the receipt of a registration notice from the market regulation administration of the China (Tianjin) Pilot Free Trade Zone, signaling the official transfer of equity interests and the conclusion of industrial and commercial change registration procedures.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
